Don't Recommend a Flozin Plus GLP-1 Agonist for Most Diabetes Patients

Buzz about CV benefits with SGLT2 inhibitors (Jardiance, etc) or GLP-1 agonists (Victoza, etc) will spark curiosity about COMBINING them.

You've probably seen the ads...that Jardiance (empagliflozin) or Victoza (liraglutide) reduce both CV risk and death in type 2 diabetes.

This sets them apart from other diabetes meds. For example, so far Invokana (canagliflozin) or Ozempic (semaglutide) only lowers CV risk.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote